Comparison of topical tranexamic versus nasal tampon in epistaxis

Comparison of topical tranexamic versus nasal tampon in epistaxis in patient who admit to Alzahra anh Kashani Hospital of Isfahan

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160130026253N3

Enrollment

162

Registered

2020-01-16

Start date

2019-03-21

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epistaxis. Epistaxis

Interventions

Intervention 1: Intervention group 1: In this group 15 cm gas was immersed in tranexamic acid at a concentration of 500 mg / ml in 5 ml and placed in the bleeding nasal duct. Intervention 2: Control g

Eligibility

Sex/Gender

All

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with unilateral idiopathic anterior epistaxis

Exclusion criteria

Exclusion criteria: Posterior epistaxis A history of bleeding disorders such as thrombocytopenia, hemophilia and platelet disorders Seizure Arterial or intravenous thrombosis Use of anticoagulants, platelets and aspirin

Design outcomes

Primary

Measure	Time frame
Stop the bleeding. Timepoint: Every 5 minutes. Method of measurement: stopwatch.;Rate of rebleeding. Timepoint: During the first 24 hours as well as the first week after intervention. Method of measurement: stopwatch.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Abootalebi Ghahnavieh

Isfahan University of medical sciences, Emergency Department, Isfahan, I. R, Iran

a_abootalebi@med.mui.ac.ir+98 31 3620 2085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026